An Open-label Extension Study to Evaluate the Long-term Safety andTolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia An Open-label Extension Study to Evaluate the Long-term Safety andTolerability of Chronocort in the ...
A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety andTolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety andTolerability of Chronocort ...
Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Congenital Adrenal Hyperplasia due to 21-hydroxylase deficiency;Therapeutic area: Diseases [C] - Con ...
Trade Name: Efmody 5 mg modified release hard capsules Product Name: Chronocort 5mg INN or Proposed INN: HYDROCORTISONE Other descriptive name: HYDROCORTISONE MICRONIZED Trade Name: Efmody 10 mg modified release hard capsules Product Name: Chronocort 10mg INN or Proposed INN: hydrocortisone Other descriptive name: HYDROCORTISONE MICRONIZED Trade Name: Efmody 5 mg modified release hard capsules Product Name: Chronocort 5mg INN or Proposed IN ...